Brief: Bioporto FY EBIT Loss Widens To DKK 41.8 Million

BioPorto A/S

22/02/2019 07:39

Feb 22 (Reuters) - Bioporto A/S  BIOPOR.CO :
    * REG-BIOPORTO ANNOUNCES ANNUAL REPORT 2018
    * 2018 REVENUE GROWTH OF 80% FROM SALES OF NGAL TEST™ IN
U.S. AND
18% IN REST OF WORLD IN 2018
    * TOTAL REVENUE OF DKK 26 MILLION IN 2018 AND AN OPERATING
LOSS OF
DKK 42 MILLION
    * REVENUE IN 2019 EXPECTED AT APPROXIMATELY DKK 40 MILLION
WITH AN
EXPECTED OPERATING LOSS OF DKK 45 MILLION
    * FY REVENUE DKK 26.0 MILLION VERSUS DKK 25.2 MILLION YEAR
AGO
    * FY EBIT LOSS DKK 41.8 MILLION VERSUS LOSS DKK 36.5 
MILLION YEAR
AGO
    * FOCUS IN 2019 WILL BE ON STRATEGIC EXECUTION AND
INCREASING
REVENUE BY 50% TO APPROXIMATELY DKK 40 MILLION
    * SAYS DRIVING FORCE WILL BE GROWING SALES OF NGAL TEST™.

Source text for Eikon:  ID:nGNE1SSDRL 
Further company coverage:  BIOPOR.CO 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))